GHRL and Parkinson disease: In in vitro and rodent models of Parkinson’s disease (PD), acute ghrelin antagonizes 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced toxicity in dopaminergic neurones of the mouse SN [6,7].